Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Joachim Deeg

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Living Beings

Dogs

Concepts & Ideas

Physiology

Chemicals & Drugs

Phenomena

Recurrence

Anatomy

Bone Marrow Cells

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Tefferi Ayalew; Verstovsek Srdan; Barosi Giovanni; Passamonti Francesco; Roboz Gail J; Gisslinger Heinz; Paquette Ronald L; Cervantes Francisco; Rivera Candido E; Deeg H Joachim; Thiele Juergen; Kvasnicka Hans M; Vardiman James W; Zhang Yanming; Bekele B Nebiyou; Mesa Ruben A; Gale Robert P; Kantarjian Hagop M
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
Deeg H Joachim
59-year-old man with MDS.
Marcondes A Mario; Bair Steven; Rabinovitch Peter S; Gooley Ted; Deeg H Joachim; Risques Rosana
No telomere shortening in marrow stroma from patients with MDS.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Joachim Deeg (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Tefferi Ayalew; Verstovsek Srdan; Barosi Giovanni; Passamonti Francesco; Roboz Gail J; Gisslinger Heinz; Paquette Ronald L; Cervantes Francisco; Rivera Candido E; Deeg H Joachim; Thiele Juergen; Kvasnicka Hans M; Vardiman James W; Zhang Yanming; Bekele B Nebiyou; Mesa Ruben A; Gale Robert P; Kantarjian Hagop M
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4563-9.
2009: Deeg H Joachim
59-year-old man with MDS.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(8):1001-2.
2009: Marcondes A Mario; Bair Steven; Rabinovitch Peter S; Gooley Ted; Deeg H Joachim; Risques Rosana
No telomere shortening in marrow stroma from patients with MDS.
Annals of hematology 2009;88(7):623-8.
2009: Carnevale-Schianca Fabrizio; Leisenring Wendy; Martin Paul J; Furlong Terry; Schoch Gary; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Kiem Hans-Peter; Storb Rainer; McDonald George B; Nash Richard A
Longitudinal assessment of morbidity and acute graft-versus-host disease after allogeneic hematopoietic cell transplantation: retrospective analysis of a multicenter phase III study.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):749-56.
2009: Deeg H Joachim
Transplantation conditioning regimens: can we say it better?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(6):653-5.
2009: Landgren Ola; Gilbert Ethel S; Rizzo J Douglas; Socié Gérard; Banks Peter M; Sobocinski Kathleen A; Horowitz Mary M; Jaffe Elaine S; Kingma Douglas W; Travis Lois B; Flowers Mary E; Martin Paul J; Deeg H Joachim; Curtis Rochelle E
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.
Blood 2009;113(20):4992-5001.
2009: Zang Dae Young; Deeg H Joachim
Allogeneic hematopoietic cell transplantation for patients with myelofibrosis.
Current opinion in hematology 2009;16(2):140-6.
2009: Mielcarek Marco; Storer Barry E; Boeckh Michael; Carpenter Paul A; McDonald George B; Deeg H Joachim; Nash Richard A; Flowers Mary E D; Doney Kristine; Lee Stephanie; Marr Kieren A; Furlong Terry; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes.
Blood 2009;113(13):2888-94.
2009: Schwartz Jeffrey L; Kopecky Kenneth J; Mathes Robert W; Leisenring Wendy M; Friedman Debra L; Deeg H Joachim
Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation.
Radiation research 2009;171(2):155-63.
2009: Oliansky Denise M; Antin Joseph H; Bennett John M; Deeg H Joachim; Engelhardt Christin; Heptinstall Kathleen V; de Lima Marcos; Gore Steven D; Potts Ronald G; Silverman Lewis R; Jones Roy B; McCarthy Philip L; Hahn Theresa
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of myelodysplastic syndromes: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(2):137-72.
2009: Bair Steven; Spaulding Emily; Parkkinen Jaakko; Shulman Howard M; Lesnikov Vladimir; Beauchamp Mary; Canonne-Hergaux François; Kowdley Kris V; Deeg H Joachim
Transplantation of allogeneic T cells alters iron homeostasis in NOD/SCID mice.
Blood 2009;113(8):1841-4.
2009: Rizzo J Douglas; Curtis Rochelle E; Socié Gérard; Sobocinski Kathleen A; Gilbert Ethel; Landgren Ola; Travis Lois B; Travis William D; Flowers Mary E D; Friedman Debra L; Horowitz Mary M; Wingard John R; Deeg H Joachim
Solid cancers after allogeneic hematopoietic cell transplantation.
Blood 2009;113(5):1175-83.
2009: Mhyre Andrew J; Marcondes A Mario; Spaulding Emily Y; Deeg H Joachim
Stroma-dependent apoptosis in clonal hematopoietic precursors correlates with expression of PYCARD.
Blood 2009;113(3):649-58.
2008: Seal Sudeshna; Hockenbery David M; Spaulding Emily Y; Kiem Hans-Peter; Abbassi Nissa; Deeg H Joachim
Differential responses of FLIPLong and FLIPShort-overexpressing human myeloid leukemia cells to TNF-alpha and TRAIL-initiated apoptotic signals.
Experimental hematology 2008;36(12):1660-72.
2008: Platzbecker Uwe; Bornhäuser Martin; Germing Ulrich; Stumpf Julian; Scott Bart L; Kröger Nicolaus; Schwerdtfeger Rainer; Böhm Alexandra; Kobbe Guido; Theuser Catrin; Rabitsch Werner; Valent Peter; Sorror Mohamed L; Ehninger Gerhard; Deeg H Joachim
Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(11):1217-25.
2008: Greenberg Peter L; Attar Eyal; Battiwalla Minoo; Bennett John M; Bloomfield Clara D; DeCastro Carlos M; Deeg H Joachim; Erba Harry P; Foran James M; Garcia-Manero Guillermo; Gore Steven D; Head David; Maness Lori J; Millenson Michael; Nimer Stephen D; O'Donnell Margaret R; Saba Hussain I; Shami Paul J; Spiers Kathy; Stone Richard M; Tallman Martin S; Westervelt Peter;
Myelodysplastic syndromes.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(9):902-26.
2008: Scott Bart L; Wells Denise A; Loken Michael R; Myerson David; Leisenring Wendy M; Deeg H Joachim
Validation of a flow cytometric scoring system as a prognostic indicator for posttransplantation outcome in patients with myelodysplastic syndrome.
Blood 2008;112(7):2681-6.
2008: Lesnikov Vladimir; Gorden Nicholas; Fausto Nelson; Spaulding Emily; Campbell Jean; Shulman Howard; Fleming Robert E; Deeg H Joachim
Transferrin fails to provide protection against Fas-induced hepatic injury in mice with deletion of functional transferrin-receptor type 2.
Apoptosis : an international journal on programmed cell death 2008;13(8):1005-12.
2008: Scott Bart L; Park J Y; Deeg H Joachim; Marr Kieren A; Boeckh Michael; Chauncey Thomas R; Appelbaum Frederick R; Storb Rainer; Storer Barry E
Pretransplant neutropenia is associated with poor-risk cytogenetic features and increased infection-related mortality in patients with myelodysplastic syndromes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(7):799-806.
2008: Furlong Terry; Kiem Hans-Peter; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Flowers Mary E D; Mielcarek Marco; Nash Richard A; Storb Rainer; Martin Paul J
Sirolimus in combination with cyclosporine or tacrolimus plus methotrexate for prevention of graft-versus-host disease following hematopoietic cell transplantation from unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(5):531-7.
2008: Marcondes Mario; Deeg H Joachim
Hematopoietic cell transplantation for patients with myelodysplastic syndromes (MDS): when, how and for whom?
Best practice & research. Clinical haematology 2008;21(1):67-77.
2008: Marcondes A Mario; Mhyre Andrew J; Stirewalt Derek L; Kim Soo-Hyun; Dinarello Charles A; Deeg H Joachim
Dysregulation of IL-32 in myelodysplastic syndrome and chronic myelomonocytic leukemia modulates apoptosis and impairs NK function.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(8):2865-70.
2008: Stirewalt Derek L; Mhyre Andrew J; Marcondes Mario; Pogosova-Agadjanyan Era; Abbasi Nissa; Radich Jerald P; Deeg H Joachim
Tumour necrosis factor-induced gene expression in human marrow stroma: clues to the pathophysiology of MDS?
British journal of haematology 2008;140(4):444-53.
2008: Friedman Debra L; Rovo Alicia; Leisenring Wendy; Locasciulli Anna; Flowers Mary E D; Tichelli Andre; Sanders Jean E; Deeg H Joachim; Socie Gerard;
Increased risk of breast cancer among survivors of allogeneic hematopoietic cell transplantation: a report from the FHCRC and the EBMT-Late Effect Working Party.
Blood 2008;111(2):939-44.
2008: Raza Azra; Reeves James A; Feldman Eric J; Dewald Gordon W; Bennett John M; Deeg H Joachim; Dreisbach Luke; Schiffer Charles A; Stone Richard M; Greenberg Peter L; Curtin Peter T; Klimek Virginia M; Shammo Jamile M; Thomas Deborah; Knight Robert D; Schmidt Michele; Wride Kenton; Zeldis Jerome B; List Alan F
Phase 2 study of lenalidomide in transfusion-dependent, low-risk, and intermediate-1 risk myelodysplastic syndromes with karyotypes other than deletion 5q.
Blood 2008;111(1):86-93.
2007: Sorror Mohamed L; Giralt Sergio; Sandmaier Brenda M; De Lima Marcos; Shahjahan Munir; Maloney David G; Deeg H Joachim; Appelbaum Frederick R; Storer Barry; Storb Rainer
Hematopoietic cell transplantation specific comorbidity index as an outcome predictor for patients with acute myeloid leukemia in first remission: combined FHCRC and MDACC experiences.
Blood 2007;110(13):4606-13.
2007: De Roos Anneclaire J; Deeg H Joachim; Davis Scott
A population-based study of survival in patients with secondary myelodysplastic syndromes (MDS): impact of type and treatment of primary cancers.
Cancer causes & control : CCC 2007;18(10):1199-208.
2007: Kerbauy Daniella B; Deeg H Joachim
Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndrome.
Experimental hematology 2007;35(11):1739-46.
2007: Campregher P V; Gooley T; Scott B L; Moravec C; Sandmaier B; Martin P J; Deeg H J; Warren E H; Flowers M E D
Results of donor lymphocyte infusions for relapsed myelodysplastic syndrome after hematopoietic cell transplantation.
Bone marrow transplantation 2007;40(10):965-71.
2007: Sorror Mohamed L; Sandmaier Brenda M; Storer Barry E; Maris Michael B; Baron Frédéric; Maloney David G; Scott Bart L; Deeg H Joachim; Appelbaum Frederick R; Storb Rainer
Comorbidity and disease status based risk stratification of outcomes among patients with acute myeloid leukemia or myelodysplasia receiving allogeneic hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4246-54.
2007: Chang Chunkang; Storer Barry E; Scott Bart L; Bryant Eileen M; Shulman Howard M; Flowers Mary E; Sandmaier Brenda M; Witherspoon Robert P; Nash Richard A; Sanders Jean E; Bedalov Antonio; Hansen John A; Clurman Bruce E; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation in patients with myelodysplastic syndrome or acute myeloid leukemia arising from myelodysplastic syndrome: similar outcomes in patients with de novo disease and disease following prior therapy or antecedent hematologic disorders.
Blood 2007;110(4):1379-87.
2007: McCune Jeannine S; Batchelder Ami; Deeg H Joachim; Gooley Ted; Cole Scott; Phillips Brian; Schoch H Gary; McDonald George B
Cyclophosphamide following targeted oral busulfan as conditioning for hematopoietic cell transplantation: pharmacokinetics, liver toxicity, and mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(7):853-62.
2007: Mhyre Andrew J; Deeg H Joachim
Control of hematopoiesis and apoptosis in MDS: more than FLIPing the coin.
Leukemia research 2007;31(6):747-9.
2007: Mesa Ruben A; Verstovsek Srdan; Cervantes Francisco; Barosi Giovanni; Reilly John T; Dupriez Brigitte; Levine Ross; Le Bousse-Kerdiles Marie-Caroline; Wadleigh Martha; Campbell Peter J; Silver Richard T; Vannucchi Alessandro M; Deeg H Joachim; Gisslinger Heinz; Thomas Deborah; Odenike Olatoyosi; Solberg Lawrence A; Gotlib Jason; Hexner Elizabeth; Nimer Stephen D; Kantarjian Hagop; Orazi Attilio; Vardiman James W; Thiele Juergen; Tefferi Ayalew;
Primary myelofibrosis (PMF), post polycythemia vera myelofibrosis (post-PV MF), post essential thrombocythemia myelofibrosis (post-ET MF), blast phase PMF (PMF-BP): Consensus on terminology by the international working group for myelofibrosis research and treatment (IWG-MRT).
Leukemia research 2007;31(6):737-40.
2007: Ying Shao Xu; Seal Sudeshna; Abbassi Nissa; Hockenbery David M; Kiem Hans-Peter; Li Xiao; Pagel John M; Gopal Ajay K; Deeg H J
Differential effects of bexarotene on intrinsic and extrinsic pathways in TRAIL-induced apoptosis in two myeloid leukemia cell lines.
Leukemia & lymphoma 2007;48(5):1003-14.
2007: Deeg H Joachim
How I treat refractory acute GVHD.
Blood 2007;109(10):4119-26.
2007: Kerbauy Daniella M B; Gooley Theodore A; Sale George E; Flowers Mary E D; Doney Kristine C; Georges George E; Greene Joanne E; Linenberger Michael; Petersdorf Effie; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed; Stirewalt Derek L; Stewart F Marc; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Hematopoietic cell transplantation as curative therapy for idiopathic myelofibrosis, advanced polycythemia vera, and essential thrombocythemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):355-65.
2007: Scott Bart L; Storer Barry E; Greene Joanne E; Hackman Robert C; Appelbaum Frederick R; Deeg H Joachim
Marrow fibrosis as a risk factor for posttransplantation outcome in patients with advanced myelodysplastic syndrome or acute myeloid leukemia with multilineage dysplasia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(3):345-54.
2006: Sale George E; Deeg H Joachim; Porter Bruce A
Regression of myelofibrosis and osteosclerosis following hematopoietic cell transplantation assessed by magnetic resonance imaging and histologic grading.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(12):1285-94.
2006: Tse William; Deeg H Joachim
Hematopoietic cell transplantation for chronic myeloproliferative disorders.
Archivum immunologiae et therapiae experimentalis 2006;54(6):375-80.
2006: Deeg H J; Maris M B; Scott B L; Warren E H
Optimization of allogeneic transplant conditioning: not the time for dogma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(10):1701-5.
2006: Deeg H Joachim; Friedman Debra; Bohr Vilhelm A; Constine Louis; Jones Irene M; Sigurdson Alice; Socié Gérard; Van Zant Gary; Wei Qingyi; Martin Paul
Transplantation and aging.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(9):893-8.
2006: Deeg H Joachim; O'Donnell Margaret; Tolar Jakub; Agarwal Rajni; Harris Richard E; Feig Stephen A; Territo Mary C; Collins Robert H; McSweeney Peter A; Copelan Edward A; Khan Shakila P; Woolfrey Ann; Storer Barry
Optimization of conditioning for marrow transplantation from unrelated donors for patients with aplastic anemia after failure of immunosuppressive therapy.
Blood 2006;108(5):1485-91.
2006: Tefferi Ayalew; Barosi Giovanni; Mesa Ruben A; Cervantes Francisco; Deeg H Joachim; Reilly John T; Verstovsek Srdan; Dupriez Brigitte; Silver Richard T; Odenike Olatoyosi; Cortes Jorge; Wadleigh Martha; Solberg Lawrence A; Camoriano John K; Gisslinger Heinz; Noel Pierre; Thiele Juergen; Vardiman James W; Hoffman Ronald; Cross Nicholas C P; Gilliland D Gary; Kantarjian Hagop;
International Working Group (IWG) consensus criteria for treatment response in myelofibrosis with myeloid metaplasia, for the IWG for Myelofibrosis Research and Treatment (IWG-MRT).
Blood 2006;108(5):1497-503.
2006: Deeg H Joachim; Storer Barry E; Boeckh Michael; Martin Paul J; McCune Jeannine S; Myerson David; Heimfeld Shelly; Flowers Mary E; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Nash Richard A; O'Donnell Paul V; Radich Jerald P; Sandmaier Brenda M; Scott Bart L; Sorror Mohamed L; Warren E Houston; Witherspoon Robert P; Woolfrey Ann; Appelbaum Frederick R; Storb Rainer
Reduced incidence of acute and chronic graft-versus-host disease with the addition of thymoglobulin to a targeted busulfan/cyclophosphamide regimen.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):573-84.
2006: Sala-Torra Olga; Hanna Colleen; Loken Michael R; Flowers Mary E D; Maris Michael; Ladne Paula A; Mason James R; Senitzer David; Rodriguez Roberto; Forman Stephen J; Deeg H Joachim; Radich Jerald P
Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(5):511-7.
2006: Leisenring Wendy; Friedman Debra L; Flowers Mary E D; Schwartz Jeffrey L; Deeg H Joachim
Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(7):1119-26.
2006: Deeg H Joachim
Transplant strategies for patients with myelodysplastic syndromes.
Current opinion in hematology 2006;13(2):61-6.
2006: Deeg H Joachim; Antin Joseph H
The clinical spectrum of acute graft-versus-host disease.
Seminars in hematology 2006;43(1):24-31.
2006: Greenberg Peter L; Baer Maria R; Bennett John M; Bloomfield Clara D; De Castro Carlos M; Deeg H Joachim; Devetten Marcel P; Emanuel Peter D; Erba Harry P; Estey Eli; Foran James; Gore Steven D; Millenson Michael; Navarro Willlis H; Nimer Stephen D; O'Donnell Margaret R; Saba Hussain I; Spiers Kathy; Stone Richard M; Tallman Martin S
Myelodysplastic syndromes clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(1):58-77.
2006: Lesnikov V A; Abbasi N; Lesnikova M P; Lazaro C A; Campbell J S; Fausto N; Deeg H J
Protection of human and murine hepatocytes against Fas-induced death by transferrin and iron.
Apoptosis : an international journal on programmed cell death 2006;11(1):79-87.
2006: Scott B L; Sandmaier B M; Storer B; Maris M B; Sorror M L; Maloney D G; Chauncey T R; Storb R; Deeg H J
Myeloablative vs nonmyeloablative allogeneic transplantation for patients with myelodysplastic syndrome or acute myelogenous leukemia with multilineage dysplasia: a retrospective analysis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):128-35.
2006: Scott Bart; Deeg H Joachim
Hemopoietic cell transplantation as curative therapy of myelodysplastic syndromes and myeloproliferative disorders.
Best practice & research. Clinical haematology 2006;19(3):519-33.
2005: Nakao Shinji; Deeg H Joachim; Ishikawa Takayuki; Marsh Judith; List Alan; Tomonaga Masao
Myelodysplastic syndrome.
International journal of hematology 2005;82(5):412-6.
2005: Kojima Seiji; Frickhofen Norbert; Deeg H Joachim; Okamoto Shinichiro; Marsh Judith; Teramura Masanao; Bacigalupo Andrea; Mizoguchi Hideaki
Aplastic anemia.
International journal of hematology 2005;82(5):408-11.
2005: Kerbauy Daniella M B; Lesnikov Vladimir; Abbasi Nissa; Seal Sudeshna; Scott Bart; Deeg H Joachim
NF-kappaB and FLIP in arsenic trioxide (ATO)-induced apoptosis in myelodysplastic syndromes (MDSs).
Blood 2005;106(12):3917-25.
2005: Kurre Peter; Johnson F Leonard; Deeg H Joachim
Diagnosis and treatment of children with aplastic anemia.
Pediatric blood & cancer 2005;45(6):770-80.
2005: Sorror Mohamed L; Leisenring Wendy; Deeg H Joachim; Martin Paul J; Storb Rainer
Twenty-year follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(10):814-5.
2005: Kerbauy Daniella M B; Chyou Faith; Gooley Ted; Sorror Mohamed L; Scott Bart; Pagel John M; Myerson David; Appelbaum Frederick R; Storb Rainer; Deeg H Joachim
Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(9):713-20.
2005: Kahl Christoph; Leisenring Wendy; Deeg H Joachim; Chauncey Thomas R; Flowers Mary E D; Martin Paul J; Sanders Jean E; Storb Rainer
Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
British journal of haematology 2005;130(5):747-51.
2005: van Besien Koen; Deeg H Joachim
Hematopoietic stem cell transplantation for myelofibrosis.
Seminars in oncology 2005;32(4):414-21.
2005: Scott Bart L; Deeg H Joachim
Hemopoietic cell transplantation for the myelodysplastic syndromes.
Archivum immunologiae et therapiae experimentalis 2005;53(4):297-307.
2005: Sorror Mohamed L; Leisenring Wendy; Deeg H Joachim; Martin Paul J; Storb Rainer
Re: Twenty-year follow-up in patients with aplastic anemia given marrow grafts from HLA-identical siblings and randomized to receive methotrexate/cyclosporine or methotrexate alone for prevention of graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):567-8.
2005: Nash Richard A; Johnston Laura; Parker Pablo; McCune Jeannine S; Storer Barry; Slattery John T; Furlong Terry; Anasetti Claudio; Appelbaum Frederick R; Lloid Michele E; Deeg H Joachim; Kiem Hans-Peter; Martin Paul J; Schubert Mark M; Witherspoon Robert P; Forman Stephen J; Blume Karl G; Storb Rainer
A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(7):495-505.
2005: Wallen Herschel; Gooley Theodore A; Deeg H Joachim; Pagel John M; Press Oliver W; Appelbaum Frederick R; Storb Rainer; Gopal Ajay K
Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3439-46.
2005: Curtis Rochelle E; Metayer Catherine; Rizzo J Douglas; Socié Gérard; Sobocinski Kathleen A; Flowers Mary E D; Travis William D; Travis Lois B; Horowitz Mary M; Deeg H Joachim
Impact of chronic GVHD therapy on the development of squamous-cell cancers after hematopoietic stem-cell transplantation: an international case-control study.
Blood 2005;105(10):3802-11.
2005: Wilson H M P; Lesnikov V; Plymate S R; Ward J; Deeg H J
High IGFBP-3 levels in marrow plasma in early-stage MDS: effects on apoptosis and hemopoiesis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(4):580-5.
2005: Scott Bart L; Storer Barry; Loken Michael R; Storb Rainer; Appelbaum Frederick R; Deeg H Joachim
Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(1):65-73.
2005: Deeg H Joachim
Optimization of transplant regimens for patients with myelodysplastic syndrome (MDS).
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2005;():167-73.
2004: Scott Bart; Deeg H Joachim; Storer Barry; Chauncey Thomas; Petersdorf Stephen; Slattery John; Appelbaum Frederick
Targeted busulfan and cyclophosphamide as compared to busulfan and TBI as preparative regimens for transplantation in patients with advanced MDS or transformation to AML.
Leukemia & lymphoma 2004;45(12):2409-17.
2004: Stewart Betty L; Storer Barry; Storek Jan; Deeg H Joachim; Storb Rainer; Hansen John A; Appelbaum Frederick R; Carpenter Paul A; Sanders Jean E; Kiem Hans-Peter; Nash Richard A; Petersdorf Effie W; Moravec Carina; Morton A James; Anasetti Claudio; Flowers Mary E D; Martin Paul J
Duration of immunosuppressive treatment for chronic graft-versus-host disease.
Blood 2004;104(12):3501-6.
2004: Deeg H Joachim; Jiang Peter Y Z; Holmberg Leona A; Scott Bart; Petersdorf Effie W; Appelbaum Frederick R
Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells.
Leukemia research 2004;28(11):1177-80.
2004: Kerbauy Daniella M Bahia; Lesnikov Vladimir; Torok-Storb Beverly; Bryant Eileen; Deeg H Joachim
Engraftment of distinct clonal MDS-derived hematopoietic precursors in NOD/SCID-beta2-microglobulin-deficient mice after intramedullary transplantation of hematopoietic and stromal cells.
Blood 2004;104(7):2202-3.
2004: Platzbecker Uwe; Kurre Peter; Guardiola Philippe; Ward Jessica L; Radich Jerald P; Kiem Hans-Peter; Deeg H Joachim
Fanconi anemia type C-deficient hematopoietic cells are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cleavage of pro-caspase-8.
Experimental hematology 2004;32(9):815-21.
2004: Li Xiao; Bryant C Eileen; Deeg H Joachim
Simultaneous demonstration of clonal chromosome abnormalities and apoptosis in individual marrow cells in myelodysplastic syndrome.
International journal of hematology 2004;80(2):140-5.
2004: Wang Linlin; Wells Denise A; Deeg H Joachim; Loken Michael R
Flow cytometric detection of nonneoplastic antigenic polymorphisms of donor origin after allogeneic marrow transplant: a report of two cases.
American journal of clinical pathology 2004;122(1):135-40.
2004: Tefferi Ayalew; Deeg H Joachim
Deciding on transplantation for myelofibrosis: setting the record straight.
Mayo Clinic proceedings. Mayo Clinic 2004;79(7):953-4.
2004: Cutler Corey S; Lee Stephanie J; Greenberg Peter; Deeg H Joachim; Pérez Waleska S; Anasetti Claudio; Bolwell Brian J; Cairo Mitchell S; Gale Robert Peter; Klein John P; Lazarus Hillard M; Liesveld Jane L; McCarthy Philip L; Milone Gustavo A; Rizzo J Douglas; Schultz Kirk R; Trigg Michael E; Keating Armand; Weisdorf Daniel J; Antin Joseph H; Horowitz Mary M
A decision analysis of allogeneic bone marrow transplantation for the myelodysplastic syndromes: delayed transplantation for low-risk myelodysplasia is associated with improved outcome.
Blood 2004;104(2):579-85.
2004: Benesch Martin; Deeg H Joachim; Wells Denise; Loken Michael
Flow cytometry for diagnosis and assessment of prognosis in patients with myelodysplastic syndromes.
Hematology (Amsterdam, Netherlands) 2004;9(3):171-7.
2004: Deeg H Joachim
What is in a name? Refined diagnostic criteria for prognostic assessment in myelodysplastic syndrome (MDS).
Leukemia research 2004;28(6):543-4.
2004: Martin Paul J; McDonald George B; Sanders Jean E; Anasetti Claudio; Appelbaum Frederick R; Deeg H Joachim; Nash Richard A; Petersdorf Effie W; Hansen John A; Storb Rainer
Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(5):320-7.
2004: Friedman Debra L; Leisenring Wendy; Schwartz Jeffrey L; Deeg H Joachim
Second malignant neoplasms following hematopoietic stem cell transplantation.
International journal of hematology 2004;79(3):229-34.
2004: Yusuf U; Frangoul H A; Gooley T A; Woolfrey A E; Carpenter P A; Andrews R G; Deeg H J; Appelbaum F R; Anasetti C; Storb R; Sanders J E
Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
Bone marrow transplantation 2004;33(8):805-14.
2004: Lesnikov Vladimir A; Lesnikova Marina P; Shulman Howard M; Wilson Heather-Marie; Hockenbery David M; Kocher Markus; Pierpaoli Walter; Deeg H Joachim
Prevention of Fas-mediated hepatic failure by transferrin.
Laboratory investigation; a journal of technical methods and pathology 2004;84(3):342-52.
2004: Deeg H Joachim
The message is not the median!
Mayo Clinic proceedings. Mayo Clinic 2004;79(2):275; author reply 275-6.
2003: Stewart B; Verdugo M; Guthrie K A; Appelbaum F; Deeg H J
Outcome following haematopoietic cell transplantation in patients with myelodysplasia and del (5q) karyotypes.
British journal of haematology 2003;123(5):879-85.
2003: Benesch M; McDonald G B; Schubert M; Appelbaum F R; Deeg H J
Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study.
Bone marrow transplantation 2003;32(11):1071-5.
2003: Benesch M; Platzbecker U; Ward J; Deeg H J; Leisenring W
Expression of FLIP(Long) and FLIP(Short) in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(12):2460-6.
2003: Deeg H Joachim; Gooley Theodore A; Flowers Mary E D; Sale George E; Slattery John T; Anasetti Claudio; Chauncey Thomas R; Doney Kristine; Georges George E; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie W; Radich Jerald; Sanders Jean E; Sandmaier Brenda M; Warren E Houston; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R
Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
Blood 2003;102(12):3912-8.
2003: Fukuda Takahiro; Hackman Robert C; Guthrie Katherine A; Sandmaier Brenda M; Boeckh Michael; Maris Michael B; Maloney David G; Deeg H Joachim; Martin Paul J; Storb Rainer F; Madtes David K
Risks and outcomes of idiopathic pneumonia syndrome after nonmyeloablative and conventional conditioning regimens for allogeneic hematopoietic stem cell transplantation.
Blood 2003;102(8):2777-85.
2003: Chen Chien-Shing; Boeckh M; Seidel K; Clark J G; Kansu E; Madtes D K; Wagner J L; Witherspoon R P; Anasetti C; Appelbaum F R; Bensinger W I; Deeg H J; Martin P J; Sanders J E; Storb R; Storek J; Wade J; Siadak M; Flowers M E D; Sullivan K M
Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;32(5):515-22.
2003: Benesch Martin; Deeg H Joachim
Hematopoietic cell transplantation for adult patients with myelodysplastic syndromes and myeloproliferative disorders.
Mayo Clinic proceedings. Mayo Clinic 2003;78(8):981-90.
2003: Platzbecker Uwe; Ward Jessica L; Deeg H Joachim
Chelerythrin activates caspase-8, downregulates FLIP long and short, and overcomes resistance to tumour necrosis factor-related apoptosis-inducing ligand in KG1a cells.
British journal of haematology 2003;122(3):489-97.
2003: Bornhauser Martin; Storer Barry; Slattery John T; Appelbaum Frederick R; Deeg H Joachim; Hansen John; Martin Paul J; McDonald George B; Nichols W Garrett; Radich Jerald; Woolfrey Ann; Jenke Andreas; Schleyer Eberhard; Thiede Christian; Ehninger Gerhard; Anasetti Claudio
Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells.
Blood 2003;102(3):820-6.
2003: Wells Denise A; Benesch Martin; Loken Michael R; Vallejo Carlos; Myerson David; Leisenring Wendy M; Deeg H Joachim
Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation.
Blood 2003;102(1):394-403.
2003: Benesch Martin; Deeg H Joachim
Hemopoietic cell transplantation for myelodysplastic syndromes.
Current hematology reports 2003;2(3):209-16.
2003: Benito Ana I; Bryant Eileen; Loken Michael R; Sale George E; Nash Richard A; John Gass M; Deeg H Joachim
NOD/SCID mice transplanted with marrow from patients with myelodysplastic syndrome (MDS) show long-term propagation of normal but not clonal human precursors.
Leukemia research 2003;27(5):425-36.
2003: Deeg H Joachim
New strategies for prevention and treatment of graft-versus-host disease and for induction of graft-versus-leukemia effects.
International journal of hematology 2003;77(1):15-21.
2002: Deeg H Joachim; Guardiola Philippe
Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis.
International journal of hematology 2002;76 Suppl 2():29-34.
2002: Deeg H Joachim; Storer Barry; Slattery John T; Anasetti Claudio; Doney Kristine C; Hansen John A; Kiem Hans-Peter; Martin Paul J; Petersdorf Effie; Radich Jerald P; Sanders Jean E; Shulman Howard M; Warren Edus H; Witherspoon Robert P; Bryant Eileen M; Chauncey Thomas R; Getzendaner Lisa; Storb Rainer; Appelbaum Frederick R
Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome.
Blood 2002;100(4):1201-7.
2002: Platzbecker Uwe; Gooley Ted; Anasetti Claudio; Appelbaum Frederick R; Clurman Bruce; Doney Kris; Chauncey Thomas; Flowers Mary E D; Myerson David; Radich Jerald P; Storb Rainer; Witherspoon Robert P; Deeg H Joachim
Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation.
Leukemia & lymphoma 2002;43(7):1409-14.
2002: Koc Sibel; Leisenring Wendy; Flowers Mary E D; Anasetti Claudio; Deeg H Joachim; Nash Richard A; Sanders Jean E; Witherspoon Robert P; Storb Rainer; Appelbaum Frederick R; Martin Paul J
Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone.
Blood 2002;100(1):48-51.
2002: Deeg H Joachim
Marrow stroma in MDS: culprit or bystander?
Leukemia research 2002;26(7):687-8.
2002: Carpenter Paul A; Appelbaum Frederick R; Corey Lawrence; Deeg H Joachim; Doney Kris; Gooley Theodore; Krueger James; Martin Paul; Pavlovic Sandra; Sanders Jean; Slattery John; Levitt Daniel; Storb Rainer; Woolfrey Ann; Anasetti Claudio
A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease.
Blood 2002;99(8):2712-9.
2002: Castro-Malaspina Hugo; Harris Richard E; Gajewski James; Ramsay Norma; Collins Robert; Dharan Bernie; King Roberta; Deeg H Joachim
Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program.
Blood 2002;99(6):1943-51.
2002: Deeg H J; Gotlib J; Beckham C; Dugan K; Holmberg L; Schubert M; Appelbaum F; Greenberg P
Soluble TNF receptor fusion protein (etanercept) for the treatment of myelodysplastic syndrome: a pilot study.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(2):162-4.
2002: Wingard John R; Vogelsang Georgia B; Deeg H Joachim
Stem cell transplantation: supportive care and long-term complications.
Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program 2002;():422-44.
2002: Furlong Terry; Leisenring Wendy; Storb Rainer; Anasetti Claudio; Appelbaum Frederick R; Carpenter Paul A; Deeg H Joachim; Doney Kristine; Kiem Hans-Peter; Nash Richard A; Sanders Jean E; Witherspoon Robert; Thompson Dianne; Martin Paul J
Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(4):206-12.
2002: Jurado Manuel; Deeg H Joachim; Storer Barry; Anasetti Claudio; Anderson Jeanne E; Bryant Eileen; Chauncey Thomas; Doney Kris; Flowers Mary E D; Hansen John; Martin Paul J; Nash Richard A; Petersdorf Effie; Radich Jerry; Sale George; Sandmaier Brenda M; Storb Rainer; Wade James; Witherspoon Robert; Appelhaum Frederick R
Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome after conditioning with busulfan and fractionated total body irradiation is associated with low relapse rate but considerable nonrelapse mortality.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(3):161-9.
2001: Benito A I; Furlong T; Martin P J; Anasetti C; Appelbaum F R; Doney K; Nash R A; Papayannopoulou T; Storb R; Sullivan K M; Witherspoon R; Deeg H J
Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease.
Transplantation 2001;72(12):1924-9.
2001: Kansu E; Gooley T; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial.
Blood 2001;98(13):3868-70.
2001: Socié G; Clift R A; Blaise D; Devergie A; Ringden O; Martin P J; Remberger M; Deeg H J; Ruutu T; Michallet M; Sullivan K M; Chevret S
Busulfan plus cyclophosphamide compared with total-body irradiation plus cyclophosphamide before marrow transplantation for myeloid leukemia: long-term follow-up of 4 randomized studies.
Blood 2001;98(13):3569-74.
2001: Zang D Y; Goodwin R G; Loken M R; Bryant E; Deeg H J
Expression of tumor necrosis factor-related apoptosis-inducing ligand, Apo2L, and its receptors in myelodysplastic syndrome: effects on in vitro hemopoiesis.
Blood 2001;98(10):3058-65.
2001: Deeg H J; Blazar B R; Bolwell B J; Long G D; Schuening F; Cunningham J; Rifkin R M; Abhyankar S; Briggs A D; Burt R; Lipani J; Roskos L K; White J M; Havrilla N; Schwab G; Heslop H E
Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL.
Blood 2001;98(7):2052-8.
2001: Schuler U S; Renner U D; Kroschinsky F; Johne C; Jenke A; Naumann R; Bornhäuser M; Deeg H J; Ehninger G
Intravenous busulphan for conditioning before autologous or allogeneic human blood stem cell transplantation.
British journal of haematology 2001;114(4):944-50.
2001: Benito A I; Milner L A; Leisenring W; Deeg H J; Woolfrey A E
Absence of major histocompatibility class II expression does not impair hematopoiesis in mice.
Experimental hematology 2001;29(9):1070-5.
2001: Deeg H J
Cytokines in graft-versus-host disease and the graft-versus-leukemia reaction.
International journal of hematology 2001;74(1):26-32.
2001: Witherspoon R P; Deeg H J; Storer B; Anasetti C; Storb R; Appelbaum F R
Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2134-41.
2001: Lesnikov V; Lesnikova M; Deeg H J
Pro-apoptotic and anti-apoptotic effects of transferrin and transferrin-derived glycans on hematopoietic cells and lymphocytes.
Experimental hematology 2001;29(4):477-89.
2001: Li Z; Deeg H J
Pros and cons of splenectomy in patients with myelofibrosis undergoing stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2001;15(3):465-7.
2001: Jurado M; Deeg H; Gooley T; Anasetti C; Chauncey T; Flowers M; Myerson D; Storb R; Appelbaum F
Haemopoietic stem cell transplantation for advanced polycythaemia vera or essential thrombocythaemia.
British journal of haematology 2001;112(2):392-6.
2001: Deeg H J; Amylon I D; Harris R E; Collins R; Beatty P G; Feig S; Ramsay N; Territo M; Khan S P; Pamphilon D; Leis J F; Burdach S; Anasetti C; Hackman R; Storer B; Mueller B
Marrow transplants from unrelated donors for patients with aplastic anemia: minimum effective dose of total body irradiation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(4):208-15.
2001: Storb R; Blume K G; O'Donnell M R; Chauncey T; Forman S J; Deeg H J; Hu W W; Appelbaum F R; Doney K; Flowers M E; Sanders J; Leisenring W
Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):39-44.
2000: Koc S; Leisenring W; Flowers M E; Anasetti C; Deeg H J; Nash R A; Sanders J E; Witherspoon R P; Appelbaum F R; Storb R; Martin P J
Thalidomide for treatment of patients with chronic graft-versus-host disease.
Blood 2000;96(12):3995-6.
2000: Furlong T; Storb R; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K; Witherspoon R; Nash R A
Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities.
Bone marrow transplantation 2000;26(9):985-91.
2000: Deeg H J; Appelbaum F R
Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.
Leukemia research 2000;24(8):653-63.
2000: Zang D Y; Deeg H J; Gooley T; Anderson J E; Anasetti C; Sanders J; Myerson D; Storb R; Appelbaum F
Treatment of chronic myelomonocytic leukaemia by allogeneic marrow transplantation.
British journal of haematology 2000;110(1):217-22.
2000: Lesnikova M; Lesnikov V; Arrighi S; Kistler G; Pierpaoli W; Deeg H J
Upregulation of interleukin-10 and inhibition of alloantigen responses by transferrin and transferrin-derived glycans.
Journal of hematotherapy & stem cell research 2000;9(3):381-92.
2000: Deeg H J; Beckham C; Loken M R; Bryant E; Lesnikova M; Shulman H M; Gooley T
Negative regulators of hemopoiesis and stroma function in patients with myelodysplastic syndrome.
Leukemia & lymphoma 2000;37(3-4):405-14.
2000: Yu C; Linsley P; Seidel K; Sale G; Deeg H J; Nash R A; Storb R
Cytotoxic T lymphocyte antigen 4-immunoglobulin fusion protein combined with methotrexate/cyclosporine as graft-versus-host disease prevention in a canine dog leukocyte antigen-nonidentical marrow transplant model.
Transplantation 2000;69(3):450-4.
2000: Deeg H J; Shulman H M; Anderson J E; Bryant E M; Gooley T A; Slattery J T; Anasetti C; Fefer A; Storb R; Appelbaum F R
Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age.
Blood 2000;95(4):1188-94.
2000: Socié G; Curtis R E; Deeg H J; Sobocinski K A; Filipovich A H; Travis L B; Sullivan K M; Rowlings P A; Kingma D W; Banks P M; Travis W D; Witherspoon R P; Sanders J; Jaffe E S; Horowitz M M
New malignant diseases after allogeneic marrow transplantation for childhood acute leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(2):348-57.
1999: Clift R A; Radich J; Appelbaum F R; Martin P; Flowers M E; Deeg H J; Storb R; Thomas E D
Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia.
Blood 1999;94(11):3960-2.
1999: Yamaguchi M; McSweeney P A; Kimball L; Gersuk G; Hong D S; Kwok W; Storb R; Beckham C; Deeg H J
Recognition of major histocompatibility complex class II antigens by two anti-HLA-DR monoclonal antibodies on canine marrow cells correlates with effects on in vitro and in vivo hematopoiesis.
Transplantation 1999;68(8):1161-71.
1999: Rowlings P A; Curtis R E; Passweg J R; Deeg H J; Socié G; Travis L B; Kingma D W; Jaffe E S; Sobocinski K A; Horowitz M M
Increased incidence of Hodgkin's disease after allogeneic bone marrow transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(10):3122-7.
1999: Storb R; Yu C; Zaucha J M; Deeg H J; Georges G; Kiem H P; Nash R A; McSweeney P A; Wagner J L
Stable mixed hematopoietic chimerism in dogs given donor antigen, CTLA4Ig, and 100 cGy total body irradiation before and pharmacologic immunosuppression after marrow transplant.
Blood 1999;94(7):2523-9.
1999: Curtis R E; Travis L B; Rowlings P A; Socié G; Kingma D W; Banks P M; Jaffe E S; Sale G E; Horowitz M M; Witherspoon R P; Shriner D A; Weisdorf D J; Kolb H J; Sullivan K M; Sobocinski K A; Gale R P; Hoover R N; Fraumeni J F; Deeg H J
Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study.
Blood 1999;94(7):2208-16.
1999: Yamaguchi M; Nadler S; Lee J W; Deeg H J
Induction of negative regulators of haematopoiesis in human bone marrow cells by HLA-DR cross-linking.
Transplant immunology 1999;7(3):159-68.
1999: Storb R; Yu C; Barnett T; Wagner J L; Deeg H J; Nash R A; Kiem H P; McSweeney P; Seidel K; Georges G; Zaucha J M
Stable mixed hematopoietic chimerism in dog leukocyte antigen-identical littermate dogs given lymph node irradiation before and pharmacologic immunosuppression after marrow transplantation.
Blood 1999;94(3):1131-6.
1999: Guardiola P; Anderson J E; Bandini G; Cervantes F; Runde V; Arcese W; Bacigalupo A; Przepiorka D; O'Donnell M R; Polchi P; Buzyn A; Sutton L; Cazals-Hatem D; Sale G; de Witte T; Deeg H J; Gluckman E
Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study.
Blood 1999;93(9):2831-8.
1999: Feinstein L C; Seidel K; Jocum J; Bowden R A; Anasetti C; Deeg H J; Flowers M E; Kansu E; Martin P J; Nash R A; Storek J; Etzioni R; Applebaum F R; Hansen J A; Storb R; Sullivan K M
Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(6):369-78.
1999: Deeg H J; Schuler U S; Shulman H; Ehrsam M; Renner U; Yu C; Storb R; Ehninger G
Myeloablation by intravenous busulfan and hematopoietic reconstitution with autologous marrow in a canine model.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(5):316-21.
1999: Deeg H J; Seidel K; Casper J; Anasetti C; Davies S; Gajeweski J L; Territo M; Ramsay N; Harris R E; Catro-Malaspina H; Collins R; Champlin R; Schoch G; King R; Howe C
Marrow transplantation from unrelated donors for patients with severe aplastic anemia who have failed immunosuppressive therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(4):243-52.
1999: Storb R; Raff R F; Graham T; Appelbaum F R; Deeg H J; Schuening F G; Sale G; Seidel K
Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1999;5(3):155-61.
1998: Martin P J; Schoch G; Gooley T; Anasetti C; Deeg H J; Nash R; Sanders J; Storb R; Appelbaum F
Methods for assessment of graft-versus-host disease.
Blood 1998;92(9):3479-81.
1998: Nafa K; Bessler M; Deeg H J; Luzzatto L
New somatic mutation in the PIG-A gene emerges at relapse of paroxysmal nocturnal hemoglobinuria.
Blood 1998;92(9):3422-7.
1998: Gersuk G M; Beckham C; Loken M R; Kiener P; Anderson J E; Farrand A; Troutt A B; Ledbetter J A; Deeg H J
A role for tumour necrosis factor-alpha, Fas and Fas-Ligand in marrow failure associated with myelodysplastic syndrome.
British journal of haematology 1998;103(1):176-88.
1998: Storb R; Yu C; Deeg H J; Georges G; Kiem H P; Mcsweeney P A; Nash R A; Sandmaier B M; Sullivan K M; Wagner J L; Walters M C
Current and future preparative regimens for bone marrow transplantation in thalassemia.
Annals of the New York Academy of Sciences 1998;850():276-87.
1998: Deeg H J; Leisenring W; Storb R; Nims J; Flowers M E; Witherspoon R P; Sanders J; Sullivan K M
Long-term outcome after marrow transplantation for severe aplastic anemia.
Blood 1998;91(10):3637-45.
1998: Yu C; Seidel K; Nash R A; Deeg H J; Sandmaier B M; Barsoukov A; Santos E; Storb R
Synergism between mycophenolate mofetil and cyclosporine in preventing graft-versus-host disease among lethally irradiated dogs given DLA-nonidentical unrelated marrow grafts.
Blood 1998;91(7):2581-7.
1998: Storb R; Raff R; Deeg H J; Graham T; Appelbaum F R; Schuening F G; Shulman H; Seidel K; Leisenring W
Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts.
International journal of radiation oncology, biology, physics 1998;40(4):961-6.
1998: Deeg H J; Socie G
Malignancies after hematopoietic stem cell transplantation: many questions, some answers.
Blood 1998;91(6):1833-44.
1998: Martin P; Nash R; Sanders J; Leisenring W; Anasetti C; Deeg H J; Storb R; Appelbaum F
Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation.
Bone marrow transplantation 1998;21(3):273-9.
1998: Deeg H J; Lesnikov V
MHC class II and negative regulators of hematopoiesis.
Archivum immunologiae et therapiae experimentalis 1998;46(5):285-91.
1997: Schuening F G; von Kalle C; Kiem H P; Appelbaum F R; Deeg H J; Pepe M; Gooley T; Graham T C; Hackman R C; Storb R
Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs.
Experimental hematology 1997;25(12):1240-5.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Deeg H J; Doney K; Martin P; Sullivan K M; Witherspoon R; Pettinger M; Bensinger W; Buckner C D; Clift R; Flowers M E; Hansen J A; Pepe M; Chauncey T; Sanders J; Thomas E D
Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1997;3(4):194-201.
1997: Lee J W; Gersuk G M; Kiener P A; Beckham C; Ledbetter J A; Deeg H J
HLA-DR-triggered inhibition of hemopoiesis involves Fas/Fas ligand interactions and is prevented by c-kit ligand.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(7):3211-9.
1997: Lee J W; Beckham C; Michel B R; Rosen H; Deeg H J
HLA-DR-mediated signals for hematopoiesis and induction of apoptosis involve but are not limited to a nitric oxide pathway.
Blood 1997;90(1):217-25.
1997: Huss R; Myerson D H; Deeg H J
Haematopoietic progenitor cells transfected with a differentiation antigen show cellular transformation and tumour growth in mice.
International journal of experimental pathology 1997;78(3):177-85.
1997: Storb R; Leisenring W; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W I; Chauncey T; Clift R A; Deeg H J; Doney K C; Flowers M E; Hansen J A; Martin P J; Sanders J E; Sullivan K M; Witherspoon R P
Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin.
Blood 1997;89(10):3890-1.
1997: Deeg H J; Lin D; Leisenring W; Boeckh M; Anasetti C; Appelbaum F R; Chauncey T R; Doney K; Flowers M; Martin P; Nash R; Schoch G; Sullivan K M; Witherspoon R P; Storb R
Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial.
Blood 1997;89(10):3880-7.
1997: Slattery J T; Clift R A; Buckner C D; Radich J; Storer B; Bensinger W I; Soll E; Anasetti C; Bowden R; Bryant E; Chauncey T; Deeg H J; Doney K C; Flowers M; Gooley T; Hansen J A; Martin P J; McDonald G B; Nash R; Petersdorf E W; Sanders J E; Schoch G; Stewart P; Storb R; Sullivan K M; Thomas E D; Witherspoon R P; Appelbaum F R
Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation.
Blood 1997;89(8):3055-60.
1997: Storb R; Yu C; Wagner J L; Deeg H J; Nash R A; Kiem H P; Leisenring W; Shulman H
Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation.
Blood 1997;89(8):3048-54.
1997: Deeg H J; Seidel K; Hong D S; Yu C; Huss R; Schuening F G; Ewel C H; Storb R
In vivo radioprotective effect of AcSDKP on canine myelopoiesis.
Annals of hematology 1997;74(3):117-22.
1997: Curtis R E; Rowlings P A; Deeg H J; Shriner D A; Socíe G; Travis L B; Horowitz M M; Witherspoon R P; Hoover R N; Sobocinski K A; Fraumeni J F; Boice J D
Solid cancers after bone marrow transplantation.
The New England journal of medicine 1997;336(13):897-904.
1997: Huss R; Deeg H J
Intrathymic maturation of CD4+ T-lymphocytes in an MHC class II deficient transplant model.
Tissue antigens 1997;49(1):70-3.
1996: Sandmaier B M; Storb R; Liu Y; Santos E B; Bryant E; Schuening F G; Deeg H J; Seidel K; Graham T
An anti-CD44 antibody does not enhance engraftment of DLA-identical marrow after low-dose total body irradiation.
Transplant immunology 1996;4(4):271-4.
1996: Nash R A; Piñeiro L A; Storb R; Deeg H J; Fitzsimmons W E; Furlong T; Hansen J A; Gooley T; Maher R M; Martin P; McSweeney P A; Sullivan K M; Anasetti C; Fay J W
FK506 in combination with methotrexate for the prevention of graft-versus-host disease after marrow transplantation from matched unrelated donors.
Blood 1996;88(9):3634-41.
1996: Huss R; Deeg H J; Gooley T; Bryant E; Leisenring W; Clift R; Buckner C D; Martin P; Storb R; Appelbaum F R
Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia.
Bone marrow transplantation 1996;18(4):767-76.
1996: Kiem H P; Leisenring W; Raff R; Deeg H J; Schuening F G; Appelbaum F R; Storb R
Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation.
Blood 1996;88(5):1896-7.
1996: Martin P J; Nelson B J; Appelbaum F R; Anasetti C; Deeg H J; Hansen J A; McDonald G B; Nash R A; Sullivan K M; Witherspoon R P; Scannon P J; Friedmann N; Storb R
Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation.
Blood 1996;88(3):824-30.
1996: Gersuk G M; Lee J W; Beckham C A; Anderson J; Deeg H J
Fas (CD95) receptor and Fas-ligand expression in bone marrow cells from patients with myelodysplastic syndrome.
Blood 1996;88(3):1122-3.
1996: Deeg H J; Pierpaoli W; Arrighi S; Seidel K; Graham T; Huss R; Yu C; Myerson D; Schuening F; Storb R
Facilitation of DLA-incompatible marrow grafts by donor-specific serum transferrin?
Transplant immunology 1996;4(2):113-6.
1996: Flowers M E; Sullivan K M; Deeg H J
Graft-versus-host reactions: anti-leukemia effects of donor T cells.
Transplantation proceedings 1996;28(3):1184-5.
1996: Kiem H P; McDonald G B; Myerson D; Spurgeon C L; Deeg H J; Sanders J E; Doney K; Appelbaum F R; Sullivan K M; Witherspoon R P; Storb R
Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):93-9.
1996: Deeg H J; Seidel K; Yu C; Nash R; Huss R; Schuening F; Storb R
Delay of radiation-induced decline and recovery of hematopoiesis following treatment with anti-HLA-DR antibody.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(2):105-11.
1996: Yu C; Storb R; Deeg H J; Graham T C; Scheuning F G; Huss R; Seidel K; Fitzsimmons W E
Tacrolimus (FK506) and methotrexate regimens to prevent graft-versus-host disease after unrelated dog leukocyte antigen (DLA) nonidentical marrow transplantation.
Bone marrow transplantation 1996;17(4):649-53.
1996: Sanders J E; Hawley J; Levy W; Gooley T; Buckner C D; Deeg H J; Doney K; Storb R; Sullivan K; Witherspoon R; Appelbaum F R
Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation.
Blood 1996;87(7):3045-52.
1996: Huss R; Hong D S; Beckham C; Storb R; Broudy V C; Deeg H J
Neutralization of stem cell factor in vitro and in vivo: dose-dependent inhibition of stromal cells and induction of granulocyte/monocyte differentiation.
Annals of hematology 1996;72(4):253-9.
1996: Sandmaier B M; Storb R; Santos E B; Krizanac-Bengez L; Lian T; McSweeney P A; Yu C; Schuening F G; Deeg H J; Graham T
Allogeneic transplant of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors.
Blood 1996;87(8):3508-13.
1996: Langston A A; Sanders J E; Deeg H J; Crawford S W; Anasetti C; Sullivan K M; Flowers M E; Storb R
Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita.
British journal of haematology 1996;92(3):758-65.
1996: Flowers M E; Zanis J; Pasquini R; Deeg H J; Ribeiro R; Longton G; Medeiros C R; Doney K; Sanders J; Bryant J
Marrow transplantation for Fanconi anaemia: conditioning with reduced doses of cyclophosphamide without radiation.
British journal of haematology 1996;92(3):699-706.
1996: Sullivan K M; Storek J; Kopecky K J; Jocom J; Longton G; Flowers M; Siadak M; Nims J; Witherspoon R P; Anasetti C; Appelbaum F R; Bowden R A; Buckner C D; Crawford S W; Deeg H J; Hansen J A; McDonald G B; Sanders J E; Storb R
A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: clinical outcome and effect on subsequent immune recovery.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 1996;2(1):44-53.
1996: Bean M A; Graham T; Appelbaum F R; Deeg H J; Schuening F; Sale G E; Leisenring W; Pepe M; Storb R
Gamma radiation of blood products prevents rejection of subsequent DLA-identical marrow grafts. Tolerance versus abrogation of sensitization to non-DLA antigens.
Transplantation 1996;61(2):334-5.
1996: Wagner J L; Deeg H J; Seidel K; Anasetti C; Doney K; Sanders J; Sullivan K M; Storb R
Bone marrow transplantation for severe aplastic anemia from genotypically HLA-nonidentical relatives. An update of the Seattle experience.
Transplantation 1996;61(1):54-61.
1996: Deeg H J; Socié G; Schoch G; Henry-Amar M; Witherspoon R P; Devergie A; Sullivan K M; Gluckman E; Storb R
Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients.
Blood 1996;87(1):386-92.
1995: Storb R; Deeg H J; Raff R; Schuening F; Yu C; Sandmaier B M; Graham T
Prevention of graft-versus-host disease. Studies in a canine model.
Annals of the New York Academy of Sciences 1995;770():149-64.
1995: Yu C; Storb R; Mathey B; Deeg H J; Schuening F G; Graham T C; Seidel K; Burnett R; Wagner J L; Shulman H; Sandmaier B M
DLA-identical bone marrow grafts after low-dose total body irradiation: effects of high-dose corticosteroids and cyclosporine on engraftment.
Blood 1995;86(11):4376-81.
1995: Hong D S; Beckham C; Huss R; Lee J W; Hockenbery D; Ledbetter J A; Deeg H J
Major histocompatibility complex class II-mediated inhibition of hematopoiesis in long-term marrow cultures involves apoptosis and is prevented by c-kit ligand.
Blood 1995;86(9):3341-52.
1995: Huss R; Firpo E; Deeg H J
Stem cell factor-induced expression of p27kip-1 during hematopoietic differentiation.
Experimental and molecular pathology 1995;63(2):129-34.
1995: Nash R A; Burstein S A; Storb R; Yang W; Abrams K; Appelbaum F R; Boone T; Deeg H J; Durack L D; Schuening F G
Thrombocytopenia in dogs induced by granulocyte-macrophage colony-stimulating factor: increased destruction of circulating platelets.
Blood 1995;86(5):1765-75.
1995: Yu C; Storb R; Braude I; Deeg H J; Schuening F G; Huss R; Graham T C
Corticotropin releasing factor with or without methotrexate for prevention of graft-versus-host disease in DLA-nonidentical unrelated canine marrow grafts.
Transplantation 1995;60(4):384-6.
1995: Doney K C; Storb R; Beach K; Anasetti C; Deeg H J; Hansen J A; Martin P J; Nash R A; Schubert M M; Sullivan K M
A toxicity study of trimetrexate used in combination with cyclosporine as acute graft-versus-host disease prophylaxis in HLA-mismatched, related donor bone marrow transplants.
Transplantation 1995;60(1):55-8.
1995: Demirer T; Petersen F B; Appelbaum F R; Barnett T A; Sanders J; Deeg H J; Storb R; Doney K; Bensinger W I; Shannon-Dorcy K
Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
International journal of radiation oncology, biology, physics 1995;32(4):1103-9.
1995: Hong D S; Graham T; Ewel C; Storb R; Deeg H J
Inhibition of hematopoiesis in long-term marrow cultures established on adherent layers from AcSDKP-treated dogs.
Experimental hematology 1995;23(7):639-44.
1995: Benyunes M C; Sullivan K M; Deeg H J; Mori M; Meyer W; Fisher L; Bensinger R; Jack M K; Hicks J; Witherspoon R
Cataracts after bone marrow transplantation: long-term follow-up of adults treated with fractionated total body irradiation.
International journal of radiation oncology, biology, physics 1995;32(3):661-70.
1995: Ehninger G; Schuler U; Renner U; Ehrsam M; Zeller K P; Blanz J; Storb R; Deeg H J
Use of a water-soluble busulfan formulation--pharmacokinetic studies in a canine model.
Blood 1995;85(11):3247-9.
1995: Storb R; Raff R F; Deeg H J; Graham T C; Schuening F G; Shulman H; Bryant E
DLA-identical marrow grafts after low-dose total-body irradiation. Addition of viable donor peripheral blood mononuclear cells does not enhance engraftment.
Transplantation 1995;59(10):1481-2.
1995: Nash R A; Seidel K; Storb R; Slichter S; Schuening F G; Appelbaum F R; Becker A B; Bolles L; Deeg H J; Graham T
Effects of rhIL-11 on normal dogs and after sublethal radiation.
Experimental hematology 1995;23(5):389-96.
1995: Huss R; Hoy C A; Deeg H J
Contact- and growth factor-dependent survival in a canine marrow-derived stromal cell line.
Blood 1995;85(9):2414-21.
1995: Deeg H J; Seidel K; Bruemmer B; Pepe M S; Appelbaum F R
Impact of patient weight on non-relapse mortality after marrow transplantation.
Bone marrow transplantation 1995;15(3):461-8.
1995: Rossetti F; Deeg H J; Hackman R C
Early pulmonary recurrence of non-Hodgkin's lymphoma after autologous marrow transplantation: evidence for reinfusion of lymphoma cells?
Bone marrow transplantation 1995;15(3):429-32.
1995: Hong D S; Huss R; Beckham C; Hoy C A; Storb R; Deeg H J
Major histocompatibility complex class II-mediated inhibition of hemopoiesis in vitro and in vivo is abrogated by c-kit ligand.
Transplantation proceedings 1995;27(1):642-3.
1995: Huss R; Hoy C A; Ottinger H; Grosse-Wilde H; Deeg H J
Cyclosporine-induced apoptosis in CD4+ T lymphocytes and computer-simulated analysis: modeling a treatment scenario for HIV infection.
Research in immunology 1995;146(2):101-8.
1995: Huss R; Hong D S; McSweeney P A; Hoy C A; Deeg H J
Differentiation of canine bone marrow cells with hemopoietic characteristics from an adherent stromal cell precursor.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(3):748-52.
1995: Huss R; Hong D S; Beckham C; Kimball L; Myerson D H; Storb R; Deeg H J
Ultrastructural localization of stem cell factor in canine marrow-derived stromal cells.
Experimental hematology 1995;23(1):33-40.
1994: Weaver C H; Petersen F B; Appelbaum F R; Bensinger W I; Press O; Martin P; Sandmaier B; Deeg H J; Hansen J A; Brunvand M
High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(12):2559-66.
1994: Huss R; Beckham C; Storb R; Deeg H J
Major histocompatibility complex class II expression is required for posttransplant immunological but not hemopoietic reconstitution in mice.
Transplantation 1994;58(12):1366-71.
1994: Weaver C H; Clift R A; Deeg H J; Storb R; Appelbaum F R; Bensinger W; Doney K; Hansen J A; Martin P O; Sanders J
Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia.
Bone marrow transplantation 1994;14(6):885-93.
1994: Clift R A; Buckner C D; Thomas E D; Bryant E; Anasetti C; Bensinger W I; Bowden R; Deeg H J; Doney K C; Fisher L D
Marrow transplantation for patients in accelerated phase of chronic myeloid leukemia.
Blood 1994;84(12):4368-73.
1994: Storb R; Raff R F; Appelbaum F R; Deeg H J; Graham T C; Schuening F G; Shulman H; Yu C; Bryant E; Burnett R
DLA-identical bone marrow grafts after low-dose total body irradiation: the effect of canine recombinant hematopoietic growth factors.
Blood 1994;84(10):3558-66.
1994: Clift R A; Buckner C D; Thomas E D; Bensinger W I; Bowden R; Bryant E; Deeg H J; Doney K C; Fisher L D; Hansen J A
Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide.
Blood 1994;84(6):2036-43.
1994: Huss R; Deeg H J
MHC antigens and haemopoiesis.
Transplant immunology 1994;2(3):171-5.
1994: Witherspoon R P; Deeg H J; Storb R
Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Transplantation science 1994;4(1):33-41.
1994: Anasetti C; Hansen J A; Waldmann T A; Appelbaum F R; Davis J; Deeg H J; Doney K; Martin P J; Nash R; Storb R
Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor.
Blood 1994;84(4):1320-7.
1994: Storb R; Etzioni R; Anasetti C; Appelbaum F R; Buckner C D; Bensinger W; Bryant E; Clift R; Deeg H J; Doney K
Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia.
Blood 1994;84(3):941-9.
1994: Storb R; Raff R F; Appelbaum F R; Deeg H J; Graham T C; Schuening F G; Sale G; Bryant E; Seidel K
Fractionated versus single-dose total body irradiation at low and high dose rates to condition canine littermates for DLA-identical marrow grafts.
Blood 1994;83(11):3384-9.
1994: Witherspoon R P; Deeg H J; Storb R
Secondary malignancies after marrow transplantation for leukemia or aplastic anemia.
Transplantation 1994;57(10):1413-8.
1994: Nash R A; Schuening F G; Seidel K; Appelbaum F R; Boone T; Deeg H J; Graham T C; Hackman R; Sullivan-Pepe M; Storb R
Effect of recombinant canine granulocyte-macrophage colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1994;83(7):1963-70.
1994: Deeg H J; Beckham C; Huss R; Myerson D; Greinix H; Appelbaum F R; Graham T; Schuening F; Storb R
Rescue from anti-MHC class II antibody-mediated marrow graft failure by c-kit ligand.
Blood 1994;83(8):2352-9.
1994: Kiem H P; Darovsky B; von Kalle C; Goehle S; Stewart D; Graham T; Hackman R; Appelbaum F R; Deeg H J; Miller A D
Retrovirus-mediated gene transduction into canine peripheral blood repopulating cells.
Blood 1994;83(6):1467-73.
1994: Bean M A; Graham T; Appelbaum F R; Deeg H J; Schuening F; Sale G E; Storb R
Gamma-irradiation of pretransplant blood transfusions from unrelated donors prevents sensitization to minor histocompatibility antigens on dog leukocyte antigen-identical canine marrow grafts.
Transplantation 1994;57(3):423-6.
1994: Deeg H J
Prophylaxis and treatment of acute graft-versus-host disease: current state, implications of new immunopharmacologic compounds and future strategies to prevent and treat acute GVHD in high-risk patients.
Bone marrow transplantation 1994;14 Suppl 4():S56-60.
1993: Deeg H J; Huss R
Major histocompatibility complex class II molecules, hemopoiesis and the marrow microenvironment.
Bone marrow transplantation 1993;12(5):425-30.
1993: Deeg H J
Graft-versus-host disease: host and donor views.
Seminars in hematology 1993;30(4 Suppl 4):110-7; discussion 118.
1993: Doney K; Buckner C D; Fisher L; Petersen F B; Sanders J; Appelbaum F R; Anasetti C; Badger C; Bensinger W; Deeg H J
Autologous bone marrow transplantation for acute lymphoblastic leukemia.
Bone marrow transplantation 1993;12(4):315-21.
1993: Storb R; Raff R F; Appelbaum F R; Deeg H J; Fitzsimmons W; Graham T C; Pepe M; Pettinger M; Sale G; van der Jagt R
FK-506 and methotrexate prevent graft-versus-host disease in dogs given 9.2 Gy total body irradiation and marrow grafts from unrelated dog leukocyte antigen-nonidentical donors.
Transplantation 1993;56(4):800-7.
1993: Greinix H T; Storb R; Sanders J E; Deeg H J; Doney K C; Sullivan K M; Witherspoon R P
Long-term survival and cure after marrow transplantation for congenital hypoplastic anaemia (Diamond-Blackfan syndrome).
British journal of haematology 1993;84(3):515-20.
1993: Raff R F; Storb R; Graham T; Deeg H J; Pepe M; Schaffer R; Sale G E; Schuening F; Appelbaum F R
What role for 15-deoxyspergualin in enhancing engraftment of unrelated, histoincompatible canine marrow grafts and preventing graft-versus-host disease?
Transplantation 1993;55(3):684-8.
1993: Loughran T P; Deeg H J; Storb R
Inhibition of canine NK activity by anti-CD18 monoclonal antibody, UV irradiation and cyclosporine.
Experimental hematology 1993;21(3):411-3.
1993: Schuening F G; Appelbaum F R; Deeg H J; Sullivan-Pepe M; Graham T C; Hackman R; Zsebo K M; Storb R
Effects of recombinant canine stem cell factor, a c-kit ligand, and recombinant granulocyte colony-stimulating factor on hematopoietic recovery after otherwise lethal total body irradiation.
Blood 1993;81(1):20-6.
1993: Schuening F; Bean M A; Deeg H J; Storb R
Prevention of graft failure in patients with aplastic anemia.
Bone marrow transplantation 1993;12 Suppl 3():S48-9.
1992: Raff R F; Storb R; Graham T; Sale G; Shulman H; Pepe M; Deeg H J; Schuening F; Appelbaum F R; Fidler J M
Succinyl acetone plus methotrexate as graft-versus-host disease prophylaxis in DLA-haploidentical canine littermate marrow grafts.
Transplantation 1992;54(5):947-8.
1992: Raff R F; Storb R; Graham T; Fidler J M; Sale G E; Johnston B; Deeg H J; Pepe M; Schuening F; Appelbaum F R
Pharmacologic, toxicologic, and marrow transplantation studies in dogs given succinyl acetone.
Transplantation 1992;54(5):813-20.
1992: Nash R A; Pepe M S; Storb R; Longton G; Pettinger M; Anasetti C; Appelbaum F R; Bowden R A; Deeg H J; Doney K
Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate.
Blood 1992;80(7):1838-45.
1992: Appelbaum F R; Brown P A; Sandmaier B M; Storb R; Fisher D R; Shulman H M; Graham T C; Schuening F G; Deeg H J; Bianco J A
Specific marrow ablation before marrow transplantation using an aminophosphonic acid conjugate 166Ho-EDTMP.
Blood 1992;80(6):1608-13.
1992: Petersen F B; Buckner C D; Appelbaum F R; Sanders J E; Bensinger W I; Storb R; Deeg H J; Witherspoon R P; Sullivan K M; Clift R A
Etoposide, cyclophosphamide and fractionated total body irradiation as a preparative regimen for marrow transplantation in patients with advanced hematological malignancies: a phase I study.
Bone marrow transplantation 1992;10(1):83-8.
1992: Deeg H J
Modification of allointeractions after blood transfusion and marrow transplantation by ultraviolet light.
Seminars in hematology 1992;29(2):95-101.
1992: Flowers M E; Doney K C; Storb R; Deeg H J; Sanders J E; Sullivan K M; Bryant E; Witherspoon R P; Appelbaum F R; Buckner C D
Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience.
Bone marrow transplantation 1992;9(3):167-73.
1992: Deeg H J; Erickson K; Storb R; Sullivan K M
Photoinactivation of lymphohemopoietic cells: studies in transfusion medicine and bone marrow transplantation.
Blood cells 1992;18(1):151-61; discussion 161-2.
1992: Appelbaum F R; Badger C C; Bernstein I D; Buckner C D; Deeg H J; Eary J F; Matthews D C; Press O W; Storb R; Thomas E D
Is there a better way to deliver total body irradiation?
Bone marrow transplantation 1992;10 Suppl 1():77-81.
1992: Storb R; Longton G; Anasetti C; Appelbaum F R; Beatty P; Bensinger W; Crawford S; Deeg H J; Doney K; Fefer A
Changing trends in marrow transplantation for aplastic anemia.
Bone marrow transplantation 1992;10 Suppl 1():45-52.
1991: Greinix H T; Ladiges W C; Graham T C; Maslan S; Raff R F; Sandmaier B M; Appelbaum F R; Schuening F G; Deeg H J; Storb R
Late failure of autologous marrow grafts in lethally irradiated dogs given anti-class II monoclonal antibody.
Blood 1991;78(8):2131-8.
1991: Storb R; Anasetti C; Appelbaum F; Bensinger W; Buckner C D; Clift R; Deeg H J; Doney K; Hansen J; Loughran T
Marrow transplantation for severe aplastic anemia and thalassemia major.
Seminars in hematology 1991;28(3):235-9.
1990: Aprile J; Gerhard-Miller L; Deeg H J
Cluster formation of canine dendritic cells and lymphocytes is calcium dependent and not inhibited by cyclosporine.
Experimental hematology 1990;18(1):32-6.
1989: Yee G C; McGuire T R; St Pierre B A; Self S G; Zager R A; Sullivan K M; Deeg H J
Minimal risk of chronic renal dysfunction in marrow transplant recipients treated with cyclosporine for 6 months.
Bone marrow transplantation 1989;4(6):691-4.
1989: Shields A F; Applebaum F R; Graham T; Deeg H J; Allalunis-Turner J; Chapman J D; Storb R
Bone marrow toxicity of total-body irradiation combined with radiosensitizers.
Radiation research 1989;120(2):364-9.
1989: Witherspoon R P; Fisher L D; Schoch G; Martin P; Sullivan K M; Sanders J; Deeg H J; Doney K; Thomas D; Storb R
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia.
The New England journal of medicine 1989;321(12):784-9.
1989: Storb R; Deeg H J; Pepe M; Doney K; Appelbaum F; Beatty P; Bensinger W; Buckner C D; Clift R; Hansen J
Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial.
British journal of haematology 1989;72(4):567-72.
1989: Appelbaum F R; Raff R F; Storb R; Deeg H J; Graham T C; Sandmaier B; Schuening F
Use of trimetrexate for the prevention of graft-versus-host disease.
Bone marrow transplantation 1989;4(4):421-4.
1989: Storb R; Deeg H J; Pepe M; Appelbaum F; Anasetti C; Beatty P; Bensinger W; Berenson R; Buckner C D; Clift R
Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial.
Blood 1989;73(6):1729-34.
1988: Martin P J; Hansen J A; Torok-Storb B; Durnam D; Przepiorka D; O'Quigley J; Sanders J; Sullivan K M; Witherspoon R P; Deeg H J
Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants.
Bone marrow transplantation 1988;3(5):445-56.
1988: Yee G C; McGuire T R; Gmur D J; Lennon T P; Deeg H J
Blood cyclosporine pharmacokinetics in patients undergoing marrow transplantation. Influence of age, obesity, and hematocrit.
Transplantation 1988;46(3):399-402.
1988: Deeg H J; Storb R; Longton G; Graham T C; Shulman H M; Appelbaum F; Thomas E D
Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: effects of exposure rate, fraction size, and fractionation interval on acute and delayed toxicity.
International journal of radiation oncology, biology, physics 1988;15(3):647-53.
1988: Sullivan K M; Witherspoon R P; Storb R; Deeg H J; Dahlberg S; Sanders J E; Appelbaum F R; Doney K C; Weiden P; Anasetti C
Alternating-day cyclosporine and prednisone for treatment of high-risk chronic graft-v-host disease.
Blood 1988;72(2):555-61.
1988: Sullivan K M; Witherspoon R P; Storb R; Weiden P; Flournoy N; Dahlberg S; Deeg H J; Sanders J E; Doney K C; Appelbaum F R
Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft-v-host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation.
Blood 1988;72(2):546-54.
1988: Yee G C; Self S G; McGuire T R; Carlin J; Sanders J E; Deeg H J
Serum cyclosporine concentration and risk of acute graft-versus-host disease after allogeneic marrow transplantation.
The New England journal of medicine 1988;319(2):65-70.
1988: Deeg H J; Aprile J; Storb R; Graham T C; Hackman R; Appelbaum F R; Schuening F
Functional dendritic cells are required for transfusion-induced sensitization in canine marrow graft recipients.
Blood 1988;71(4):1138-40.
1988: Yee G C; Lennon T P; Gmur D J; Cheney C L; Oeser D; Deeg H J
Effect of obesity on cyclosporine disposition.
Transplantation 1988;45(3):649-51.
1988: Storb R; Deeg H J; Applebaum F R; Schuening F; Sandmaier B; Raff R F; Graham T
Failure of anti-Ia monoclonal antibody to abrogate transfusion-induced sensitization and prevent marrow graft rejection in DLA-identical canine littermates.
Transplantation 1988;45(2):505-6.
1988: Storb R; Deeg H J; Fisher L; Appelbaum F; Buckner C D; Bensinger W; Clift R; Doney K; Irle C; McGuffin R
Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials.
Blood 1988;71(2):293-8.
1988: Ladiges W C; Pesando J M; Severns E; Longton G; Deeg H J; Storb R
Selective inhibition of the canine mixed lymphocyte response by HLA-DR and DP-reactive monoclonal antibodies.
Transplantation 1988;45(2):484-8.
1988: Ladiges W; Deeg H J; Pesando J; Storb R
Effect of anti-Ia monoclonal antibodies on in vitro immune responses of canine cells.
American journal of veterinary research 1988;49(2):147-51.
1988: Storb R; Raff R F; Appelbaum F R; Schuening F; Sandmaier B; Shulman H; Deeg H J; Graham T
Failure of antithymocyte serum postgrafting to overcome "resistance" to DLA-nonidentical canine marrow grafts.
Transplantation 1988;45(1):236-9.
1987: Storb R; Deeg H J; Appelbaum F R; Schuening F W; Raff R F; Graham T C
The biology of graft rejection in a canine model of marrow transplantation.
Transplantation proceedings 1987;19(6 Suppl 7):18-22.
1987: Deeg H J; Atkinson K; Weiden P W; Storb R
Mechanisms of tolerance in canine radiation chimeras.
Transplantation proceedings 1987;19(6 Suppl 7):75-81.
1987: Lennon T P; Yee G C; Kennedy M S; Torok-Storb B; Burstein S A; Deeg H J
Monitoring of cyclosporine therapy with in vitro biological assays.
Transplantation 1987;44(6):799-804.
1987: Schuening F; Storb R; Goehle S; Meyer J; Graham T C; Deeg H J; Appelbaum F R; Sale G E; Graf L; Loughran T P
Facilitation of engraftment of DLA-nonidentical marrow by treatment of recipients with monoclonal antibody directed against marrow cells surviving radiation.
Transplantation 1987;44(5):607-13.
1987: Deeg H J; Raff R F; Severns E; Szer J; Storb R
Two monoclonal antibodies recognizing subpopulations of canine T lymphocytes with or without suppressor/cytotoxic functions.
Methods and findings in experimental and clinical pharmacology 1987;9(11):755-9.
1987: Deeg H J; Severns E; Raff R F; Sale G E; Storb R
Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
Transplantation 1987;44(5):621-32.
1987: Deeg H J; Ladiges W C; Aprile J; Schuening F; Raff R F; Storb R
Monoclonal antibodies to canine differentiation antigens.
Methods and findings in experimental and clinical pharmacology 1987;9(11):749-53.
1987: Doney K; Storb R; Buckner C D; McGuffin R; Witherspoon R; Deeg H J; Appelbaum F R; Sullivan K M; Thomas E D
Treatment of aplastic anemia with antithymocyte globulin, high-dose corticosteroids, and androgens.
Experimental hematology 1987;15(3):239-42.
1987: Yee G C; Kennedy M S; Gmur D J; Self S G; Deeg H J
Monitoring cyclosporin concentrations in marrow transplant recipients: comparison of two assay methods.
Bone marrow transplantation 1987;1(3):289-95.
1987: Yee G C; Lennon T P; Gmur D J; Kennedy M S; Deeg H J
Effect of age on cyclosporine pharmacokinetics in marrow transplant recipients.
Transplantation proceedings 1987;19(1 Pt 2):1704-5.
1987: Raff R F; Loughran T P; Deeg H J; Aprile J A; Graham T C; Sale G E; Storb R
Role of radiation-resistant large granular lymphocytes in the rejection of unrelated DLA-nonidentical marrow grafts in dogs.
Transplantation proceedings 1987;19(1 Pt 3):2718-20.
1987: Deeg H J; Aprile J; Severns E; Rajantie J; Schmidt E; Raff R F; Green K E; Storb R
Phenotypic and functional alterations of recipient lymphocytes after transfusion of UV-irradiated and normal blood--implications for marrow transplantation.
Transplantation proceedings 1987;19(1 Pt 3):2709-14.
1986: Yee G C; Lennon T P; Gmur D G; Carlin J; Schaffer R L; Kennedy M S; Deeg H J
Clinical pharmacology of cyclosporine in patients undergoing bone marrow transplantation.
Transplantation proceedings 1986;18(6 Suppl 5):153-9.
1986: Storb R; Kolb H J; Deeg H J; Weiden P L; Appelbaum F; Graham T C; Thomas E D
Prevention of graft-versus-host disease by immunosuppressive agents after transplantation of DLA-nonidentical canine marrow.
Bone marrow transplantation 1986;1(2):167-77.
1986: Deeg H J; Sullivan K M; Buckner C D; Storb R; Appelbaum F R; Clift R A; Doney K; Sanders J E; Witherspoon R P; Thomas E D
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiation.
Bone marrow transplantation 1986;1(2):151-7.
1986: Yee G C; Lennon T P; Gmur D J; Kennedy M S; Deeg H J
Age-dependent cyclosporine: pharmacokinetics in marrow transplant recipients.
Clinical pharmacology and therapeutics 1986;40(4):438-43.
1986: Raff R F; Deeg H J; Loughran T P; Graham T C; Aprile J A; Sale G E; Storb R
Characterization of host cells involved in resistance to marrow grafts in dogs transplanted from unrelated DLA-nonidentical donors.
Blood 1986;68(4):861-8.
1986: Klingemann H G; Deeg H J; Self S; Thomas E D; Storb R
Is race a risk factor for allogeneic marrow transplantation?
Bone marrow transplantation 1986;1(1):87-94.
1986: Deeg H J; Aprile J; Graham T C; Appelbaum F R; Storb R
Ultraviolet irradiation of blood prevents transfusion-induced sensitization and marrow graft rejection in dogs.
Blood 1986;67(2):537-9.
1985: Storb R; Deeg H J; Thomas E D; Appelbaum F R; Buckner C D; Cheever M A; Clift R A; Doney K C; Flournoy N; Kennedy M S
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host disease.
Blood 1985;66(3):698-702.
1985: Szer J; Deeg H J; Severns E; Storb R
DLA-D-specific suppressor cells characterized by monoclonal antibodies.
Transplantation 1985;39(2):187-92.
1984: Aprile J A; Deeg H J; Wulff J C; Raff R F
Purified canine monocytes fail to confer concanavalin-A responsiveness to accessory-cell-depleted lymphocytes.
Experimental hematology 1984;12(1):45-51.
1983: Wulff J C; Springmeyer S C; Deeg H J; Storb R
Canine bronchoalveolar cells: antigen-presenting macrophages are Ia-positive, lymphocytes are of non-B lineage.
Blut 1983;47(5):263-70.
1983: Urban C; Wulff J C; Deeg H J; Raff R F; Durkopp N; Storb R
Analysis of alloreactive and cytotoxic canine lymphocytes and their precursors with murine monoclonal antibodies.
Transplantation 1983;35(5):469-73.
1982: Wulff J C; Tsoi M S; Aprile J; Deeg H J; Durkopp N; Storb R
Stimulation of canine lymphocyte subpopulations separated nonlytically by monoclonal anti-T and polyclonal anti-B cell antibodies.
Blut 1982;45(5):309-16.
1982: Wulff J C; Durkopp N; Aprile J; Tsoi M S; Springmeyer S C; Deeg H J; Storb R
Two monoclonal antibodies (DLy-1 and DLy-6) directed against canine lymphocytes.
Experimental hematology 1982;10(7):609-19.
1982: Atkinson K; Shulman H M; Deeg H J; Weiden P L; Graham T C; Thomas E D; Storb R
Acute and chronic graft-versus-host disease in dogs given hemopoietic grafts from DLA-nonidentical littermates. Two distinct syndromes.
The American journal of pathology 1982;108(2):196-205.
1980: Atkinson K; Deeg H J; Storb R; Weiden P L; Gerhard-Miller L; Torok-Storb B J; Seigneuret M; Thomas E D
Canine lymphocyte subpopulations.
Experimental hematology 1980;8(7):821-9.
1980: Atkinson K; Storb R; Weiden P L; Deeg H J; Gerhard-Miller L; Thomas E D
In vitro tests correlating with presence or absence of graft-vs-host disease in DLA nonidentical canine radiation chimeras: evidence that clonal abortion maintains stable graft-host tolerance.
Journal of immunology (Baltimore, Md. : 1950) 1980;124(4):1808-14.
1980: Deeg H J; Storb R; Gerhard-Miller L; Shulman H M; Weiden P L; Thomas E D
Cyclosporin A, a powerful immunosuppressant in vivo and in vitro in the dog, fails to induce tolerance.
Transplantation 1980;29(3):230-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Joachim Deeg

Research Profile (preview)

Procedures

Disorders

Living Beings

Concepts & Ideas

Physiology

Chemicals & Drugs

Phenomena

Anatomy

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Joachim Deeg (preview)

All Publications